Mirador Therapeutics has raised $250M to advance clinical trials. Read about the Series B financing led by T. Rowe Price and ...

On January 12, NP-G2-044 (Prilukae), a novel oral fascin inhibitor earned ODD for the treatment of pancreatic cancer. This designation covers the use of the agent as monotherapy and in combination ...

Tempus AI, Inc. (NASDAQ:TEM) is one of the best Nancy Pelosi Stocks to buy in 2026. On January 27, Tempus AI, Inc. (NASDAQ:TEM) confirmed that its Immune Profile Score Test accurately predicts patient ...

Advancements in MS include promising therapies like BTK inhibitors and myelin repair, evolving biomarkers, and a focus on cognition, signaling a promising future in precision medicine.

In part one of season two of MobiHealthNews’ Emerging Technologies series, Mark Zhang, acting assistant under secretary for ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. No two people are the same. Precision medicine, sometimes ...

Precision medicine is one of the most promising and novel approaches to controlling excessive healthcare costs and providing a meaningful benefit through improved disease diagnosis, treatment and ...

In this interview, Kavitha Lokesh, Vice President of Global Life Sciences R&D Industry Solutions at Cognizant, discusses her role and the impact of precision medicine. With 26 years in IT, primarily ...

Singapore Office Expands APAC Presence to Seven Locations, Delivering Enhanced Local Expertise and Global Scale BETHESDA, Md.